financetom
Business
financetom
/
Business
/
Hydro One's Q3 Earnings Meet Forecast On Higher Revs; National Bank Says Overall Impact "Neutral"
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Hydro One's Q3 Earnings Meet Forecast On Higher Revs; National Bank Says Overall Impact "Neutral"
Nov 7, 2024 7:20 AM

09:57 AM EST, 11/07/2024 (MT Newswires) -- Hydro One ( HRNNF ) was fluctuating between modest gains and losses in early trade Thursday after its third quarter earnings met expectations on improved revenues.

National Bank said the overall impact of the result is "neutral". It added: "With another solid quarter in the books and the company's capital plan through 2027 intact, we expect little change to our estimates following the company's conference call."

For its part, Hydro One ( HRNNF ) reported Q3 2024 GAAP diluted earnings of $371 million, or $0.62 per share, up 3.3% from $357 million, or $0.59, a year earlier. It met the Capital IQ forecast.

Revenue for the quarter ended Sept. 30 was $2.19 billion, up 13.5% from $1.93 billion a year earlier. This beat a Capital IQ forecast of $2.006 billion.

The company said higher revenues resulted from Ontario Energy Board (OEB) approved 2024 transmission and distribution rates, as well as higher average monthly peak demand and energy consumption, which were partially offset by higher income tax expense, higher depreciation, amortization and asset removal costs and higher financing charges.

Subsequent to quarter end, Hydro One ( HRNNF ) filed settlement proposals with OEB for the 5-year rate applications for its B2M Limited Partnership and the Niagara Reinforcement Limited Partnership and reached settlement-in-principle for its Chatham to Lakeshore Transmission Line Project, with plans to file the proposal soon. Subsequent to quarter end, the government approved an Environmental Assessment Report for the Waasigan Transmission Line.

Hydro One's ( HRNNF ) quarterly cash dividend of $0.3142 per share is payable on Dec. 31, to shareholders of record on Dec. 11, 2024.

In Q3, the company's capital investments totaled $773 million, compared to $638 million in the same period of 2023, with assets placed in-service amounting to $597 million, down from $699 million a year earlier.

Price: 44.11, Change: -0.07, Percent Change: -0.16

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
INSIGHT-Crypto exchanges rushed to list Trump's coin - leaving many losers and some big winners
INSIGHT-Crypto exchanges rushed to list Trump's coin - leaving many losers and some big winners
Jul 14, 2025
* $TRUMP was listed in an average of 4 days by exchanges, vs 129 days for other big coins * Three crypto exchanges say they moved to list $TRUMP fast because of customer demand * Exchanges say no corners were cut in vetting the coin for listing * White House says Trump coin poses 'no conflicts of interest' By Hannah...
Ultragenyx Receives FDA Complete Response Letter for UX111 Gene Therapy
Ultragenyx Receives FDA Complete Response Letter for UX111 Gene Therapy
Jul 14, 2025
05:42 AM EDT, 07/14/2025 (MT Newswires) -- Ultragenyx Pharmaceutical ( RARE ) said Friday the US Food and Drug Administration has issued a complete response letter for its biologics license application for UX111, a gene therapy targeting Sanfilippo syndrome type A, a rare, inherited genetic disorder. The FDA's letter cited the need for additional information and improvements related to chemistry,...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Rocket Pharmaceuticals Names Christopher Stevens as Chief Operating Officer
Rocket Pharmaceuticals Names Christopher Stevens as Chief Operating Officer
Jul 14, 2025
05:40 AM EDT, 07/14/2025 (MT Newswires) -- Rocket Pharmaceuticals ( RCKT ) said Friday it appointed Christopher Stevens as chief operating officer, effective July 7, replacing Kinnari Patel, who transitioned to president and head of research and development. Stevens most recently served as executive vice president and chief patient supply officer of Spark Therapeutics, according to a regulatory filing. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved